Informationen: Dieses ist nicht die aktuellste Version des Datenmodells. Eine Versionsübersicht finden Sie links unter Versionen. Die aktuellste Version finden Sie hier.
Informationen:
Fehler:
ID
29809
Beschreibung
Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT00956436
Link
https://clinicaltrials.gov/show/NCT00956436
Stichworte
Versionen (2)
- 20.04.18 20.04.18 -
- 20.09.21 20.09.21 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
20. April 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Hepatocellular Carcinoma NCT00956436
Eligibility Hepatocellular Carcinoma NCT00956436
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Hepatocellular Carcinoma NCT00956436
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
Liver carcinoma Advanced | Target Lesion Measurable Quantity
Item
histologically-confirmed advanced hcc with at least 1 target lesion measurable by modified recist.
boolean
C2239176 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C2986546 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0205179 (UMLS CUI [1,2])
C2986546 (UMLS CUI [2,1])
C1513040 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Child-Pugh Classification
Item
child-pugh score a5 or a6.
boolean
C2347612 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of ≤2.
boolean
C1520224 (UMLS CUI [1])
CNS metastases | Metastatic malignant neoplasm to brain
Item
known central nervous system or brain metastases.
boolean
C0686377 (UMLS CUI [1])
C0220650 (UMLS CUI [2])
C0220650 (UMLS CUI [2])
Therapeutic procedure Against IGF1R
Item
prior anti-igf-1r therapy.
boolean
C0087111 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C4044495 (UMLS CUI [1,3])
C0521124 (UMLS CUI [1,2])
C4044495 (UMLS CUI [1,3])
Systemic therapy Liver carcinoma Advanced | Local Therapy Restricted Relationship Disease Progression
Item
prior systemic therapy for advanced hcc. prior local therapies are only permitted if subjects have documented disease progression according to modified recist.
boolean
C1515119 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C1517925 (UMLS CUI [2,1])
C0443288 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0242656 (UMLS CUI [2,4])
C2239176 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C1517925 (UMLS CUI [2,1])
C0443288 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0242656 (UMLS CUI [2,4])
Cancer treatment Concurrent
Item
concurrent anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C0205420 (UMLS CUI [1,2])
Myocardial Infarction | Chronic heart failure
Item
history of myocardial infarction within 12 months prior to day 1 or chronic heart failure.
boolean
C0027051 (UMLS CUI [1])
C0264716 (UMLS CUI [2])
C0264716 (UMLS CUI [2])
Hepatitis
Item
acute hepatitis
boolean
C0019158 (UMLS CUI [1])
Fibrolamellar hepatocellular carcinoma
Item
fibrolamellar hcc
boolean
C0334287 (UMLS CUI [1])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])